Mel Eckersley-Maslin's Avatar

Mel Eckersley-Maslin

@meleckmas

Lab head in stem cell and cancer epigenetics at PeterMac, UniMelb πŸ‡¦πŸ‡ΊπŸ§¬ Scientist, mum, dreamer She/her. Views are my own www.eckmaslab.com

1,147
Followers
841
Following
42
Posts
04.11.2023
Joined
Posts Following

Latest posts by Mel Eckersley-Maslin @meleckmas

Flyer for symposium: https://ctrlepiedit.sciencesconf.org/

Flyer for symposium: https://ctrlepiedit.sciencesconf.org/

Very excited to announce the FIRST symposium on epigenome editing! These tools are becoming widely used in mol bio, ag & therapy. It's time to bring leaders together to discuss this rapidly growing and exciting field. And why not in Paris! Please register & share! (1/2) ctrlepiedit.sciencesconf.org

09.03.2026 13:15 πŸ‘ 52 πŸ” 31 πŸ’¬ 3 πŸ“Œ 5
Preview
Up to $1.4 billion in medical research remains unused under government cap Researchers say securing funding has become increasingly tough, with many left with no choice but to spend a disproportionate amount of time applying for grants.

More than 60% of Australian medical researchers left active research roles between 2019 & 2024 because they could not make ends meet - while my costings from the PBO suggest the govt could more than double annual spending from the MRFF without any effect on its base level of funding.

09.03.2026 04:45 πŸ‘ 130 πŸ” 47 πŸ’¬ 5 πŸ“Œ 3
Preview
Accessory subunits of PRC2 mimic H3K27me3 to restrict the spread of Polycomb domains Some proteins mimic the repressive mark H3K27me3, but the physiological relevance of this phenomenon was unclear. Agius et al. show that the PRC2 subunits JARID2 and PALI1 mimic H3K27me3 to antagonize...

1/ 🧡 In our new paper, we show that JARID2 and PALI1 mimic H3K27me3 to antagonise PRC2. www.cell.com/molecular-ce...

04.03.2026 23:58 πŸ‘ 55 πŸ” 23 πŸ’¬ 1 πŸ“Œ 2
Post image

🚨 New paper from our lab just published in Nature🚨

www.nature.com/articles/s41...

Discover how 🌱 tumour formation is shaped by tissue context from the very beginning. Cancer is not driven by genetics alone

✨Fantastic team led by Greta Skrupskelyte, Eduardo Rojo, @hariajith.bsky.social

04.03.2026 16:08 πŸ‘ 95 πŸ” 37 πŸ’¬ 9 πŸ“Œ 7

Try spinning down your antibodies before using. You can also add some tween to your wash buffers

03.03.2026 19:55 πŸ‘ 2 πŸ” 0 πŸ’¬ 1 πŸ“Œ 0

Frustrated I can’t be in person at #KSEpigenetics26. Unfortunately I couldn’t travel to Geneva from Australia due to the conflict in the Middle East.

Hoping everyone has a great conference and I’ll be able to join in person next time!

03.03.2026 09:05 πŸ‘ 4 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Please wait whilst we redirect you All content on this site: Copyright Β© 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.

Losing sleep over #iPSC transgene silencing after differentiation?
Same here.

Bright in iPSCs.
Gone after differentiation.

Our paper in @cp-cellstemcell.bsky.social maps what actually keeps expression onπŸ‘‡
www.cell.com/cell-stem-ce...
πŸ”— Free access (50 days):
www.sciencedirect.com/science/auth...

19.02.2026 18:54 πŸ‘ 12 πŸ” 10 πŸ’¬ 1 πŸ“Œ 0
Post image

2026 Winner of the Lorne Genome Julian Wells Medal: Christine Wells (no relation!) @stemcellsystems.bsky.social congratulations, well deserved!!

18.02.2026 00:18 πŸ‘ 13 πŸ” 5 πŸ’¬ 1 πŸ“Œ 0
Tongtong Wang presenting at Lorne Genome 2026

Tongtong Wang presenting at Lorne Genome 2026

Tongtong Wang @petermaccc.bsky.social kicking off the computational Biology parallel session introducing EmbryoRadar, a machine learning model to identify developmental programs reactivated in cancer.

16.02.2026 00:32 πŸ‘ 2 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0

So exciting to see ASSCR partner with @isscr.org to support Australasian student and ECR researchers to attend the ISSCR Annual meeting in Montreal!! This Joint Travel Award, the first of its kind, will enable more interactions with the international community for our EMCR members!!

#stemcells

09.02.2026 06:39 πŸ‘ 3 πŸ” 2 πŸ’¬ 0 πŸ“Œ 0

New ISSCR-ASSCR joint travel awards to support Australian students and EMCRs to attend @isscr.org annual meeting in Montreal

07.02.2026 23:38 πŸ‘ 2 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0
Post image

Our new preprint on SMCHD1! We’ve shown SMCHD1’s ATPase activity is critical for function in vivo, and excitingly a new DNA binding domain neighbouring the ATPase domain activates the enzymatic function, which is important for normal chromatin binding.
urldefense.com/v3/__https:/...

06.02.2026 07:56 πŸ‘ 33 πŸ” 14 πŸ’¬ 1 πŸ“Œ 1
Post image

Lovely lab hike in Werribee Gorge to celebrate the EckMasLab’s 5th birthday πŸŽ‚

05.02.2026 21:30 πŸ‘ 12 πŸ” 1 πŸ’¬ 0 πŸ“Œ 1
A Triumvirate of Transformation: Oncogene, Ontogeny, and Plasticity Summary:. Cancer cells display extensive heterogeneity that influences therapy response and clinical outcome, yet the underlying mechanisms remain incompletely understood. Recent studies reveal that t...

New Spotlight in @aacrjournals.bsky.social

#Oncogene Γ— #Ontogeny Γ— #Plasticity shape leukemia biology & therapy response.

Two complementary studies show: mutations alone don’t explain disease behaviorβ€”developmental state and cellular plasticity matter.

aacrjournals.org/bloodcancerd...

🩸🧬
EpiSci

04.02.2026 18:28 πŸ‘ 7 πŸ” 4 πŸ’¬ 1 πŸ“Œ 0
Post image

Institut Pasteur (@pasteur.fr) is recruiting new young PIs to open new groups in the Institute. Deadline is February 9th! Don't miss the opportunity!

27.01.2026 18:56 πŸ‘ 34 πŸ” 49 πŸ’¬ 0 πŸ“Œ 0

SS18::SSX activates Polycomb target genes without BAF ❌
Instead, transcription relies on EP300 via the SS18 QPGY domain
www.biorxiv.org/content/10.6...
➑️ Coactivator targeting emerges as a new therapeutic strategy in synovial sarcoma 🎯
Team work from @banitolab.bsky.social and @uoe-igc.bsky.social

28.01.2026 10:20 πŸ‘ 22 πŸ” 16 πŸ’¬ 3 πŸ“Œ 0
SS18-SSX co-opts P300 to sustain oncogenic transcription independent of SWI/SNF activity Synovial sarcoma is driven by the SS18-SSX fusion oncoprotein, which has been assumed to promote tumorigenesis through its incorporation into the SWI/SNF chromatin remodeling complexes. Accordingly, therapeutic efforts have focused on targeting SS18-SSX containing SWI/SNF assemblies, yet these approaches have produced limited clinical benefit. Here, we demonstrate that SS18-SSX sustains oncogenic transcription independent of SWI/SNF activity. Despite efficient degradation and dismantling of SWI/SNF complexes, fusion occupancy at target loci and associated gene expression programs remain largely intact. Instead, we identify the acetyltransferase P300 as an essential co-factor supporting SS18-SSX chromatin binding and transcriptional activation. Targeting P300 displaces the fusion from chromatin, suppresses its transcriptional output, compromising synovial sarcoma viability. Notably, dual PROTAC mediated degradation of P300 and SWI/SNF produces strong synergistic effects, broadly disrupting SS18-SSX localization and function. These findings redefine the mechanistic basis of synovial sarcoma and reveal a mechanistically anchored therapeutic strategy for targeting its core oncogenic driver. ### Competing Interest Statement C.R.V. has been a consultant for Flare Therapeutics, Roivant Sciences and C4 Therapeutics; has served on the advisory boards of KSQ Therapeutics, Syros Pharmaceuticals and Treeline Biosciences; has received research funding from Boehringer Ingelheim and Treeline Biosciences; and owns stock in Treeline Biosciences. S.A.A. has been a consultant and/or shareholder for Neomorph, Imago Biosciences, Hyku Therapeutics, C4 Therapeutics, Accent Therapeutics and Nimbus Therapeutics; and has received research support from Janssen and Syndax. N.O.C. is a co-founder, shareholder and management consultant for PhenoTherapeutics Ltd; and a shareholder in Amplia Therapeutics Ltd All other authors declare no financial interests UKRI, EP/X039633/1 Worldwide Cancer Research, https://ror.org/031tfbz57, 21-0271 Science Foundation Ireland, https://ror.org/0271asj38, 18/SIRG/5573

Synovial sarcoma is driven almost exclusively by a single oncofusion – SS18-SSX

For years, the assumptions on disease mechanisms were simple:

➑️ SS18-SSX works by hijacking SWI/SNF chromatin remodeling activity

Our new study shows that assumption was wrong πŸ§΅πŸ‘‡

www.biorxiv.org/content/10.6...

28.01.2026 09:54 πŸ‘ 30 πŸ” 12 πŸ’¬ 2 πŸ“Œ 3

#FragileNuclesome is back tomorrow! Join us to hear about exciting talks from:

- @au-ho-yu.bsky.social in @robklose.bsky.social's group about transcriptional control by SET1/MLL complexes

- @gcloner.bsky.social at @epicypher.bsky.social about the histone PTM landscape of the immune system

27.01.2026 18:24 πŸ‘ 9 πŸ” 5 πŸ’¬ 0 πŸ“Œ 0
Post image

Great to catch up with alumni @nchoy.bsky.social who stopped by to visit the lab. So great to hear about your internship adventures with @robertife.bsky.social and see you doing so well!

23.01.2026 07:00 πŸ‘ 8 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0
Preview
Medical Research Matters

Right now, the Government is starving medical research of full funding, even as it claims that science and research are national priorities. If our leaders truly value science as much as they say, then they must back their words with actionβ€”and fund it properly.

Join the campaign!

23.01.2026 05:23 πŸ‘ 99 πŸ” 44 πŸ’¬ 4 πŸ“Œ 6
Preview
Convergent evolution of scavenger cell development at brain borders - Nature Transcription factor osr2 is identified as a specific marker and regulator of mural lymphatic endothelial cell (muLEC) differentiation and maintenance, and muLECs and border-associated macrophages sha...

We’re delighted to see this out today! Latest work from the lab reveals insights into the evolution of brain immunity and the developmental and evolutionary plasticity of lymphatic endothelial cells.
www.nature.com/articles/s41...

21.01.2026 20:41 πŸ‘ 76 πŸ” 25 πŸ’¬ 13 πŸ“Œ 1

Humbled to have recieved NHMRC funding to understand molecular underpinnings of breast cancer plasticity.

Sadly, the bleak 8% success means many deserving applications went unfunded. Australia is missing out on scientific discoveries and all the direct and indirect benefits this brings our society.

14.01.2026 07:46 πŸ‘ 10 πŸ” 0 πŸ’¬ 1 πŸ“Œ 0
Post image

πŸ” ASSCR Call for Reviewers (2026)
PhD-qualified members are invited to join the Abstract & Awards reviewer panel.
πŸ—“οΈ Commitment Aug–Nov | ~20–30 abstracts
πŸ“… Apply by 12 Jan 2026
πŸ‘‰ docs.google.com/forms/d/e/1F...
#ASSCR #StemCells

06.01.2026 03:00 πŸ‘ 0 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0
Preview
Most researchers miss out on innovation grants while medical fund sits on $25b Nine in 10 Australian researchers had their β€œideas grant” applications rejected last year, even as Australia’s medical investment fund sits on $5 billion more than it was designed to hold.

The government can’t claim that medical research is a priority while failing to treat it as one. Nine in 10 leading researchers in Australia are missing out on government support for world‑class proposals, leaving exceptional talent uncertain about their future.

03.01.2026 23:32 πŸ‘ 108 πŸ” 48 πŸ’¬ 2 πŸ“Œ 2
Preview
Just quit Quitting projects in science is hard, but we should be doing a lot more of it.

Blog post: Just quit
Quitting projects in science is hard, but we should be doing a lot more of it.

open.substack.com/pub/arjunraj...

30.12.2025 15:02 πŸ‘ 186 πŸ” 50 πŸ’¬ 13 πŸ“Œ 14
Post image

Celebrating a wonderful end to 2025! Wishing everyone a happy festive season and happy new year

16.12.2025 09:35 πŸ‘ 15 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0
Video thumbnail

Australia’s medical and scientific research sectors save lives and are vital to our economy. The government has to step up and lean in to their potential.

It’s small-minded and short-sighted to force them to wither on the vine, when we have money put aside for this purpose in the Future Fund.

07.12.2025 22:25 πŸ‘ 48 πŸ” 20 πŸ’¬ 2 πŸ“Œ 0
Preview
Half the Funding. Half the Future. - AAMRI The Medical Research Future Fund (MRFF) was designed to deliver $1 billion each year in new, lifesaving funding for medical research. We know through financial modelling that the full amount can be re...

The Medical Research Future Fund (MRFF) funds medical research in Australia. Only half the funds have been released. If you're an Australian and able to vote please use the form below to email your local MP to release the full amount of the MRFF
aamri.org.au/mrff/

16.11.2025 21:14 πŸ‘ 7 πŸ” 7 πŸ’¬ 0 πŸ“Œ 0
Post image

Great first day of stem cell science on the beach at #ASSCR2025! Here is our @asscr.bsky.social president opening the conference. Highlights include keynote from @josh-brickman.bsky.social and presentation of @ausstemcell.bsky.social 2025 Metcalf awards. Congratulations to the worthy recipients!

10.11.2025 08:54 πŸ‘ 5 πŸ” 2 πŸ’¬ 0 πŸ“Œ 0
Preview
Speakers β€” Lorne Genome No description found

Last chance! Early bird rates and oral presentation abstract submissions for Lorne Genome 𝐞𝐧𝐝 ππ¨π―πžπ¦π›πžπ« πŸ•π­π‘, πŸπŸŽπŸπŸ“ - only one week away: https://www.lornegenome.org/registrations

We have a fantastic lineup of national and international speakers: https://www.lornegenome.org/speakers. Join us!

30.10.2025 21:30 πŸ‘ 6 πŸ” 6 πŸ’¬ 0 πŸ“Œ 0